drugset / Trial / NCT03492047

N-acetyl Cysteine Effect in Peripheral Neuropathy in Cancer Patients

NCT03492047 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to evaluate the effect of N-acetyl cysteine in combination with paclitaxel on the clinical outcomes of patients with peripheral neuropathy, paclitaxel-induced peripheral neuropathy affect quality of life in cancer patients. new therapeutic approches such as the antioxidant N-acetyl cysteine, showed to has neuroprotective effect, the aim of the study is to evaluate the effect of N- acetylcysteine(NAC) administration in the prevention of paclitaxel-Induced peripheral neuropathy.

Timeline

Start
2018-04-01
Primary completion
2019-04-01
Completion
2019-06-30

Drugs

EvaluationDrugModalityDoseRoute
Background Paclitaxel Small molecule 80 mg/m2 Intravenous